419 related articles for article (PubMed ID: 31196369)
21. Immunotherapy in small-cell lung cancer: from molecular promises to clinical challenges.
Pavan A; Attili I; Pasello G; Guarneri V; Conte PF; Bonanno L
J Immunother Cancer; 2019 Aug; 7(1):205. PubMed ID: 31383005
[TBL] [Abstract][Full Text] [Related]
22. Challenges in the treatment of small cell lung cancer in the era of immunotherapy and molecular classification.
Caliman E; Fancelli S; Petroni G; Gatta Michelet MR; Cosso F; Ottanelli C; Mazzoni F; Voltolini L; Pillozzi S; Antonuzzo L
Lung Cancer; 2023 Jan; 175():88-100. PubMed ID: 36493578
[TBL] [Abstract][Full Text] [Related]
23. Small-Cell Lung Cancer-An Update on Targeted and Immunotherapies.
McNamee N; da Silva IP; Nagrial A; Gao B
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175833
[TBL] [Abstract][Full Text] [Related]
24. Evolving role of immunotherapy in small cell lung cancer.
Barrows ED; Blackburn MJ; Liu SV
Semin Cancer Biol; 2022 Nov; 86(Pt 3):868-874. PubMed ID: 35192928
[TBL] [Abstract][Full Text] [Related]
25. Small cell lung cancer: a slightly less orphan disease after immunotherapy.
Remon J; Aldea M; Besse B; Planchard D; Reck M; Giaccone G; Soria JC
Ann Oncol; 2021 Jun; 32(6):698-709. PubMed ID: 33737119
[TBL] [Abstract][Full Text] [Related]
26. Abscopal effect of radiation therapy and nivolumab in a patient with combined small-cell lung cancer: a case report.
Wang W; Li L; Wu S; Shen J; Huang C; Chen Y; Li S
Immunotherapy; 2022 Aug; 14(12):909-914. PubMed ID: 35787148
[TBL] [Abstract][Full Text] [Related]
27. Progress and challenges in the treatment of small cell lung cancer.
Tartarone A; Giordano P; Lerose R; Rodriquenz MG; Conca R; Aieta M
Med Oncol; 2017 Jun; 34(6):110. PubMed ID: 28456992
[TBL] [Abstract][Full Text] [Related]
28. Molecular Characterization and Therapeutic Approaches to Small Cell Lung Cancer: Imaging Implications.
Park H; Tseng SC; Sholl LM; Hatabu H; Awad MM; Nishino M
Radiology; 2022 Dec; 305(3):512-525. PubMed ID: 36283111
[TBL] [Abstract][Full Text] [Related]
29. Immune Checkpoint Inhibitors in Small Cell Lung Cancer: A Partially Realized Potential.
Armstrong SA; Liu SV
Adv Ther; 2019 Aug; 36(8):1826-1832. PubMed ID: 31209697
[TBL] [Abstract][Full Text] [Related]
30. Small cell lung cancer: where do we go from here?
Byers LA; Rudin CM
Cancer; 2015 Mar; 121(5):664-72. PubMed ID: 25336398
[TBL] [Abstract][Full Text] [Related]
31. m
Zhang Z; Zhang C; Luo Y; Wu P; Zhang G; Zeng Q; Wang L; Yang Z; Xue L; Zheng B; Zeng H; Tan F; Xue Q; Gao S; Sun N; He J
BMC Med; 2021 Nov; 19(1):284. PubMed ID: 34802443
[TBL] [Abstract][Full Text] [Related]
32. Second-line treatments of small-cell lung cancers.
Baize N; Monnet I; Greillier L; Quere G; Kerjouan M; Janicot H; Vergnenegre A; Auliac JB; Chouaid C
Expert Rev Anticancer Ther; 2017 Nov; 17(11):1033-1043. PubMed ID: 28849951
[TBL] [Abstract][Full Text] [Related]
33. A new hope: the immunotherapy in small cell lung cancer.
Li Q; Yuan D; Ma C; Liu Y; Ma L; Lv T; Song Y
Neoplasma; 2016; 63(3):342-50. PubMed ID: 26925794
[TBL] [Abstract][Full Text] [Related]
34. Prospects of targeted and immune therapies in SCLC.
Hendriks LEL; Menis J; Reck M
Expert Rev Anticancer Ther; 2019 Feb; 19(2):151-167. PubMed ID: 30590971
[No Abstract] [Full Text] [Related]
35. Radiation therapy for extensive-stage small-cell lung cancer in the era of immunotherapy.
Tian Y; Ma J; Jing X; Zhai X; Li Y; Guo Z; Yu J; Zhu H
Cancer Lett; 2022 Aug; 541():215719. PubMed ID: 35597478
[TBL] [Abstract][Full Text] [Related]
36. Challenging the recalcitrant disease-developing molecularly driven treatments for small cell lung cancer.
Mak DWS; Li S; Minchom A
Eur J Cancer; 2019 Sep; 119():132-150. PubMed ID: 31445197
[TBL] [Abstract][Full Text] [Related]
37. Optimal drugs for second-line treatment of patients with small-cell lung cancer.
Rossi A; Sacco PC; Sgambato A; Casaluce F; Santabarbara G; Palazzolo G; Maione P; Gridelli C
Expert Opin Pharmacother; 2016; 17(7):969-76. PubMed ID: 26878692
[TBL] [Abstract][Full Text] [Related]
38. Novel therapeutic strategies for recurrent SCLC.
Moliner L; Zhang B; Lamberti G; Ardizzoni A; Byers LA; Califano R
Crit Rev Oncol Hematol; 2023 Jun; 186():104017. PubMed ID: 37150311
[TBL] [Abstract][Full Text] [Related]
39. When is surgery indicated for small-cell lung cancer?
Veronesi G; Bottoni E; Finocchiaro G; Alloisio M
Lung Cancer; 2015 Dec; 90(3):582-9. PubMed ID: 26520187
[TBL] [Abstract][Full Text] [Related]
40. [Apatinib as Salvage Therapy for Heavily Pretreated SCLC].
Li F; Tao H
Zhongguo Fei Ai Za Zhi; 2018 Jul; 21(7):565-570. PubMed ID: 30037379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
